Skip to main content
. 2023 Jun 13;381:e074684. doi: 10.1136/bmj-2022-074684

Fig 4.

Fig 4

Adjusted annual breast cancer mortality rates in 512 447 women with early breast cancer with oestrogen receptor (ER) positive or ER negative disease by calendar period of diagnosis, according to whether their cancer was screen detected. Rates are adjusted for age at diagnosis, tumour size, number of positive nodes, tumour grade, time since diagnosis, breast cancer laterality, index of multiple deprivation, and region of residence. Vertical lines are 95% confidence intervals. Further details are in figure S14